Results 231 to 240 of about 72,161 (311)

GLP-1 agonist-associated presentations to unscheduled care: An opportunistic pilot study. [PDF]

Br J Clin Pharmacol
Thomas O, Coulson JM.
europepmc   +1 more source

Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss. [PDF]

J Clin Med
Arora G, Conde KR, Desouza CV.
europepmc   +1 more source

Positron emission tomography to assess drug occupancy at peripheral and central incretin receptors. [PDF]

EBioMedicine
Khalil A, Velikyan I, Xiong M, Bossart M, Wagner M, Eriksson O.   +5 more
europepmc   +1 more source

Insulinoma Unmasked By Tirzepatide: A Rare Case of Postprandial Hypoglycemia In a Nondiabetic Patient. [PDF]

JCEM Case Rep
Polisky M, Kamel D, Ku JH.
europepmc   +1 more source

Incretin-based therapies for obesity and disordered eating: optimising care in general practice. [PDF]

Fam Med Community Health
Atlantis E, Wu R, Dixon J.
europepmc   +1 more source

Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans.

J Clin Endocrinol Metab
Di Giuseppe G, Gliozzo G, Ciccarelli G, Carciero L, Brunetti M, Soldovieri L, Quero G, Cinti F, Nista EC, De Lucia SS, Gasbarrini A, Alfieri S, Pontecorvi A, Mari A, Hartmann B, Holst JJ, Giaccari A, Mezza T.   +17 more
europepmc   +1 more source

Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges. [PDF]

Diabetes
Chen AS, Batsis JA.
europepmc   +1 more source

The Satiety Awakens: Metformin Restores Intestinal Lipid Sensing. [PDF]

Diabetes
López M, Nogueiras R.
europepmc   +1 more source

Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes. [PDF]

Sci Rep
Takemoto M, Zhang BS, Hayashi A, Yamagata H, Yoshida Y, Koshizaka M, Onishi S, Yamaga M, Yoshida T, Hashimoto T, Ohtake N, Ishikawa T, Takizawa H, Hiwasa T.   +13 more
europepmc   +1 more source

Injectable drugs for weight management. [PDF]

Aust Prescr
Yates N, South TL.
europepmc   +1 more source